Moneyball Medicine: Andrew A. Radin with Progress on twoXAR August 31, 2020 Podcast Harry welcomes back Andrew A. Radin, CEO of the drug discovery startup twoXAR, where scientists model pathogenesis computationally to identify potential drug molecules and, ideally shaving years off the drug development process. READ MORE